Continuous Subcutaneous Insulin Infusion (CSII) Combined with Oral Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis of Randomized, Controlled Trials

• Main Authors: Hui Li (Author), Aimin Yang (Author), Shi Zhao (Author), Elaine YK Chow (Author), Mohammad Javanbakht (Author), Yinhui Li (Author), Dandan Lin (Author), Lijuan Xu (Author), Deng Zang (Author), Kai Wang (Author), Li Ma (Author)
• Format: Book
• Published: MDPI AG, 2022-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The clinical efficacy of continuous subcutaneous insulin infusion (CSII) therapy combined with six classes of oral glucose-lowering drugs (GLDs) (TZDs/metformin/acarbose/GLP-1 receptor agonist/SGLT-2 inhibitor/DPP-4 inhibitor) was evaluated by a network meta-analysis to provide an evidence-based ref...